Fibrocell Science, Inc. Deferred Tax Assets, Valuation Allowance
Fibrocell Science, Inc. had Deferred Tax Assets, Valuation Allowance of $72.12 million as of 2018-12-31, per its 10-K filed 2019-03-27.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance
us-gaap:DeferredTaxAssetsValuationAllowance · last filed 2019-03-27
- 2018-12-31: Deferred Tax Assets, Valuation Allowance $72.12M.
- 2017-12-31: Deferred Tax Assets, Valuation Allowance $67.29M.
- 2016-12-31: Deferred Tax Assets, Valuation Allowance $95.84M.
- 2015-12-31: Deferred Tax Assets, Valuation Allowance $90.05M.
| Period end | Deferred Tax Assets, Valuation Allowance | Deferred Tax Assets, Valuation Allowance as first filed |
|---|---|---|
| 2018-12-31 | $72.12M 10-K · filed 2019-03-27 | |
| 2017-12-31 | $67.29M 10-K · filed 2019-03-27 | |
| 2016-12-31 | $95.84M 10-K · filed 2018-03-19 | |
| 2015-12-31 | $90.05M 10-K · filed 2017-03-09 | |
| 2014-12-31 | $74.14M 10-K · filed 2016-03-10 | |
| 2013-12-31 | $62.50M 10-K · filed 2016-03-10 | |
| 2012-12-31 | $52.31M 10-K · filed 2015-03-13 | |
| 2011-12-31 | $41.19M 10-K/A · filed 2014-06-02 | $52.31M 10-K · filed 2013-04-01 |
| 2010-12-31 | $41.19M 10-K · filed 2013-04-01 |